Phase 3
N=40
Preoperative Gabapentine for Carpal Tunnel
Carpal Tunnel Syndrome
Bottom Line
View on ClinicalTrials.gov: NCT01632215 ↗Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Jun 2014
Primary outcome: Primary: Pain Intensity — 0.3; 0.4 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 3
- Interventions
- Gabapentine (Drug); Sugar pill (Other)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Federal University of São Paulo
- Primary completion
- Aug 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Intensity |
0.3; 0.4 | — |
| SECONDARY Chronic Pain |
5.5; 6.9; 2.4; 3.4; 0.3; 0.6 | <0.05 sig |
Summary
The purpose of this study was to evaluate the postoperative analgesic effect of preoperative gabapentine for carpal tunnel syndrome surgery.
Eligibility Criteria
Inclusion Criteria
- carpal tunnel syndrome
Exclusion Criteria
- disorientation, psychiatric disease, myocardial ischemia, hypertension, arrhythmia, another pain syndrome, drug user, and pregnant
Data sourced from ClinicalTrials.gov (NCT01632215). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.